acetylcysteine has been researched along with Community Acquired Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ju, Y; Ma, Y; Wang, T; Zhang, Q | 1 |
| Aliavi, AL; Kurbanova, GA | 1 |
2 trial(s) available for acetylcysteine and Community Acquired Infection
| Article | Year |
|---|---|
N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial.
Topics: Acetylcysteine; Adult; Antioxidants; Community-Acquired Infections; Female; Humans; Inflammation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pneumonia; Superoxide Dismutase; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |
[Nitric oxide metabolism in the inclusion of N-acetylcysteine into the complex therapy of patients with community-acquired pneumonia].
Topics: Acetylcysteine; Adolescent; Adult; Anti-Infective Agents; Biomarkers; Breath Tests; Community-Acquired Infections; Drug Therapy, Combination; Erythrocytes; Expectorants; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Male; Nitric Oxide; Pneumonia, Bacterial; Treatment Outcome | 2007 |